Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 59,355 |
|
|||||
| News | - | ||||||
| Day High | 8.34 | Low High |
|||||
| Day Low | 7.70 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| XBiotech Inc | XBIT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.34 | -4.14% | 7.87 | 16:16:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.10 | 7.70 | 8.34 | 7.87 | 8.21 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,374 | 59,355 | US$ 7.94 | US$ 471,162 | - | 3.05 - 9.96 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:04 | formt | 260 | US$ 7.87 | USD |
XBiotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 240.76M | 30.44M | - | 4.01M | -32.9M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
XBiotech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XBIT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.64 | 8.55 | 7.50 | 8.11 | 80,379 | 0.23 | 3.01% |
| 1 Month | 8.18 | 9.96 | 7.50 | 8.75 | 104,328 | -0.31 | -3.79% |
| 3 Months | 4.62 | 9.96 | 4.4419 | 7.56 | 76,279 | 3.25 | 70.35% |
| 6 Months | 3.81 | 9.96 | 3.51 | 6.75 | 46,784 | 4.06 | 106.56% |
| 1 Year | 3.32 | 9.96 | 3.05 | 5.79 | 50,675 | 4.55 | 137.05% |
| 3 Years | 17.04 | 18.46 | 3.00 | 8.58 | 61,537 | -9.17 | -53.81% |
| 5 Years | 9.48 | 33.20 | 3.00 | 14.34 | 137,672 | -1.61 | -16.98% |
XBiotech Description
| XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. |
